In conclusion, the present data clearly demonstrate that administration of APSAE reduces metabolic factors influencing diabetic nephropathy such as blood glucose, albumin, total protein creatinine and HbA1c in experimental diabetes. This evidence concerns the gene ALB and diabetes mellitus.